• 1
    Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350362.
  • 2
    Denburg JA. Bone marrow in atopy and asthma: hematopoietic mechanisms in allergic inflammation. Immunol Today 1999;20:111113.
  • 3
    Foster PS. Allergic networks regulating eosinophilia. Am J Respir Cell Mol Biol 1999;21:451454.
  • 4
    Adamko D, Lacy P, Moqbel R. Eosinophil function in allergic inflammation: from bone marrow to tissue response. Curr Allergy Asthma Rep 2004;4:149158.
  • 5
    Cameron L, Christodoulopoulos P, Lavigne F, Nakamura Y, Eidelman D, McEuen A et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000;164:15381545.
  • 6
    Park CS, Choi YS, Ki SY, Moon SH, Jeong SW, Uh ST et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur Respir J 1998;12:872878.
  • 7
    Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci USA 1993;90:24662470.
  • 8
    Martinez FD, Solomon S, Holberg CJ, Graves PE, Baldini M, Erickson RP. Linkage of circulating eosinophils to markers on chromosome 5q. Am J Respir Crit Care Med 1998;158:17391744.
  • 9
    Rioux JD, Stone VA, Daly MJ, Cargill M, Green T, Nguyen H et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet 1998;63:10861094.
  • 10
    Freeburn RW, Gale RE, Linch DC. Activating point mutations in the betaC chain of the GM-CSF, IL-3 and IL-5 receptors are not a major contributory factor in the pathogenesis of acute myeloid leukaemia. Br J Haematol 1998;103:6671.
  • 11
    Hong SJ, Lee SY, Kim HB, Kim JH, Kim BS, Choi SO et al. IL-5 and thromboxane A2 receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma. J Allergy Clin Immunol 2005;115:758763.
  • 12
    Kollintza A, Worthington J, John S, Ollier WE, Hajeer AH. A new polymorphism in the promoter of the interleukin 5 receptor alpha subunit (IL-5RA) gene. Immunogenetics 1998;48:6566.
  • 13
    Park BL, Kim LH, Choi YH, Lee JH, Rhim T, Lee YM et al. Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 2004;49:517527.
  • 14
    Rohrbach M, Frey U, Kraemer R, Liechti-Gallati S. A variant in the gene for GM-CSF, I117T, is associated with atopic asthma in a Swiss population of asthmatic children. J Allergy Clin Immunol 1999;104:247248.
  • 15
    Weiland SK, Von Mutius E, Hirsch T, Duhme H, Fritzsch C, Werner B et al. Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification. Eur Respir J 1999;14:862870.
  • 16
    Liu X, Beaty TH, Deindl P, Huang SK, Lau S, Sommerfeld C et al. Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German multicenter atopy study. J Allergy Clin Immunol 2003;112:382388.
  • 17
    Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999;103:11731179.
  • 18
    Niggemann B, Illi S, Madloch C, Volkel K, Lau S, Bergmann R et al. Histamine challenges discriminate between symptomatic and asymptomatic children. MAS-Study Group. Multicentre allergy study. Eur Respir J 2001;17:246253.
  • 19
    Schedel M, Carr D, Klopp N, Woitsch B, Illig T, Stachel D et al. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol 2004;114:11001105.
  • 20
    Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:12531261.
  • 21
    Yamamoto N, Sugiura H, Tanaka K, Uehara M. Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels. J Dermatol Sci 2003;33:121126.
  • 22
    Borger P, Ten Hacken NH, Vellenga E, Kauffman HF, Postma DS. Peripheral blood T lymphocytes from asthmatic patients are primed for enhanced expression of interleukin (IL)-4 and IL-5 mRNA: associations with lung function and serum IgE. Clin Exp Allergy 1999;29:772779.
  • 23
    Johnson BV, Bert AG, Ryan GR, Condina A, Cockerill PN. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol Cell Biol 2004;24:79147930.
  • 24
    He JQ, Ruan J, Chan-Yeung M, Becker AB, Dimich-Ward H, Pare PD et al. Polymorphisms of the GM-CSF genes and the development of atopic diseases in at-risk children. Chest 2003;123(3 Suppl.):438S.
  • 25
    Schweiger A, Stern D, Lohman IC, Baldini M, Martinez FD, Halonen M. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3. J Allergy Clin Immunol 2001;107:505510.
  • 26
    Jonsson UB, Bystrom J, Stalenheim G, Venge P. Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms. Clin Exp Allergy 2002;32:10921095.